MODIFIED OLIGONUCLEOTIDE FOR TREATING POLYCYSTIC KIDNEY DISEASE

Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17. La présente invention concerne des méthodes pour le traitement d'une maladie polykystique des reins, comprenant...

Full description

Saved in:
Bibliographic Details
Main Authors GARG, Rekha, LEE, Edmund Chun Yu
Format Patent
LanguageEnglish
French
Published 17.10.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17. La présente invention concerne des méthodes pour le traitement d'une maladie polykystique des reins, comprenant la polykystose rénale autosomique dominante, au moyen d'oligonucléotides modifiés ciblés vers miR-17.
Bibliography:Application Number: WO2024US24006